Pharma
Sarepta’s gene therapy faced internal FDA doubts. Now, a teen has died
The death is heating up concerns around the FDA’s approval process.
The latest developments in accelerated approvals, tracking policy changes and industry innovations driving today's healthcare conversation.
The death is heating up concerns around the FDA’s approval process.
The fast-lane approval process has raised concerns about oversight.
New rules give the FDA more power to enforce post-approval trial standards.
Centers for Medicare and Medicaid Services spent $68b on 38 fast-tracked drugs.
The agency created the pathway in response to the HIV/AIDS epidemic.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.